A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment’s effectiveness…
Read More »Metastatic
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…
Read More »With medical advances, more than 169,000 people in the United States are living with metastatic breast cancer. Addressing debilitating symptoms…
Read More »